Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of investment securities | (108,447) | (330,398) |
| Maturity of investment securities | 176,500 | 262,190 |
| Payment of milestone and contingent payments in connection with asset acquisition | — | (98,838) |
| Purchases of property and equipment | (10,301) | (297) |
| Net cash provided by (used in) investing activities | 57,752 | (167,343) |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock, net of issuance costs | 14,725 | 17,794 |
| Net cash provided by financing activities | 14,725 | 17,794 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's capex?
- Acadia Pharmaceuticals (ACAD) reported capex of $5.09M in Q2 2026.
- How has Acadia Pharmaceuticals's capex changed year-over-year?
- Acadia Pharmaceuticals's capex increased by 1613.5% year-over-year, from $297K to $5.09M.
- What is the long-term trend for Acadia Pharmaceuticals's capex?
- Over 3 years (2021 to 2025), Acadia Pharmaceuticals's capex has grown at a 61.1% compound annual growth rate (CAGR), from $1.12M to $4.69M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Acadia Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude